Home Press Center Information for shareholders and investors

Update on the previously announced corporate event regarding Teva Pharmaceutical Ind. depositary receipts

15 September 2026

Dear clients!

We inform you about an update to the information regarding the previously announced corporate event related to the depositary receipts of Teva Pharmaceutical Ind, ISIN: US8816242098.

Corporate event details:

Parameter	Value
Event type	Conversion / Mandatory exchange (Exchange offers)
Mandatory indicator	Mandatory
Effective date	September 14, 2026
Exchange ratio	1:1
Fraction rounding	Rounding down
ISIN of credited instrument	IL0006290147

If you have any additional questions, please contact us using the details below:

Almaty: +7 701 006 41 81
Astana: +7 701 006 41 80
WhatsApp: +7 707 357 31 70
sales@halykfinance.kz

Sincerely,
JSC «Halyk Finance»

+7 727 339 43 77 +7 727 339 43 88

halykfinance@halykfinance.kz

The Company does not guarantee profit or the absence of losses when trading in securities. The Client is aware of the risks inherent in securities trading and has the financial ability to assume such risks and bear any losses incurred in this regard. The Company shall not be liable for any losses arising from investments made based on any recommendations, forecasts, reviews, or other information.

JSC «Halyk Finance». License for securities market activities No. 3.2.229/7, issued by the National Bank of the Republic of Kazakhstan on November 4, 2016.

Developed by – «Panther Web Solutions»

Some illustrations and text materials on the website are created using artificial intelligence technologies.